| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |